← Leaderboards
Paul Joseph Goodfellow
Washington University
$8,639,266
Attributed
$10,567,570
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$11,767,570 · 13
By mechanism
R01$8,191,393 · 5
P50$1,750,645 · 3
R21$1,170,032 · 3
P30$655,500 · 2
Top collaborators
- Elaine R Mardis5 shared
- David G Mutch4 shared
- Heather D Hampel3 shared
- Casey Cosgrove2 shared
Most similar at Washington University
Same institution · by research overlap
- Ross Leigh Cagan$25,056,984
- Sanjay Jain$27,367,157
- Jeffrey F Moley$810,481
- Gerald Louis Andriole$6,419,713
- Stephanie Ann Fritz$8,750,405
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMutationTumorInheritedMolecularEndometrial CarcinomaMismatch RepairCancer PatientWomanGene MutationDefectDetectionGeneticFamilyMethylationLinkBasePlayGenesCancer RiskFamily MemberAdjuvant TherapyIncidenceNeoplasm /Cancer Genetics
Grant awards (44)
Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers$443,629
R01 · FY2022 · CA · contact PI
Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers$481,481
R01 · FY2021 · CA · contact PI
Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers$503,159
R01 · FY2020 · CA · contact PI
Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers$519,730
R01 · FY2019 · CA · contact PI
Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers$531,474
R01 · FY2018 · CA · contact PI
COPY NUMBER VARIANTS AND EARLY-ONSET BREAST CANCER$333,019
R01 · FY2013 · CA · contact PI
COPY NUMBER VARIANTS AND EARLY-ONSET BREAST CANCER$619,638
R01 · FY2012 · CA · contact PI
ATR Mutation in Endometrial Cancer$287,808
R21 · FY2012 · CA · contact PI
COPY NUMBER VARIANTS AND EARLY-ONSET BREAST CANCER$621,400
R01 · FY2011 · CA · contact PI
ATR Mutation in Endometrial Cancer$308,239
R21 · FY2011 · CA · contact PI
Identifying inherited endometrial cancer & the environmental and genetic factors$177,710
P50 · FY2011 · CA · contact PI
SPORE in Endometrial Cancer$500,000
P50 · FY2010 · CA · contact PI
Identifying inherited endometrial cancer & the environmental and genetic factors$190,493
P50 · FY2010 · CA · contact PI
SPORE in Endometrial Cancer$700,000
P50 · FY2009 · CA · contact PI
Defective DNA Mismatch Repair in Endometrial Cancers$277,450
R01 · FY2009 · CA · contact PI
Identifying inherited endometrial cancer & the environmental and genetic factors$127,003
P50 · FY2009 · CA · contact PI
FGFR2 MUTATIONS IN INTERMEDIATE RISK ENDOMETRIAL CANCERS$111,332
R21 · FY2009 · CA · contact PI
Administrative Core$55,439
P50 · FY2009 · CA · contact PI
FGFR2 MUTATIONS IN INTERMEDIATE RISK ENDOMETRIAL CANCERS$309,653
R21 · FY2008 · CA · contact PI
Defective DNA Mismatch Repair in Endometrial Cancers$277,450
R01 · FY2008 · CA · contact PI
A Murine Model for Endometrial Tumorigenesis$267,657
R01 · FY2008 · CA · contact PI
Core--Hereditary Cancer Facility$163,811
P30 · FY2008 · CA · contact PI
Cancer Genetics Program$52,602
P30 · FY2008 · CA · contact PI
Defective DNA Mismatch Repair in Endometrial Cancers$277,450
R01 · FY2007 · CA · contact PI
A Murine Model for Endometrial Tumorigenesis$252,162
R01 · FY2007 · CA · contact PI
Core--Hereditary Cancer Facility$171,645
P30 · FY2007 · CA · contact PI
Cancer Genetics Program$55,110
P30 · FY2007 · CA · contact PI
Defective DNA Mismatch Repair in Endometrial Cancers$285,737
R01 · FY2006 · CA · contact PI
A Murine Model for Endometrial Tumorigenesis$260,158
R01 · FY2006 · CA · contact PI
Core--Hereditary Cancer Facility$66,050
P30 · FY2006 · CA · contact PI
Defective DNA Mismatch Repair in Endometrial Cancers$292,613
R01 · FY2005 · CA
A Murine Model for Endometrial Tumorigenesis$266,882
R01 · FY2005 · CA
Core--Hereditary Cancer Facility$64,126
P30 · FY2005 · CA
DEFECTIVE DNA MISMATCH REPAIR IN ENDOMETRIAL CANCERS$308,000
R01 · FY2004 · CA
A Murine Model for Endometrial Tumorigenesis$280,581
R01 · FY2004 · CA
Core--Hereditary Cancer Facility$62,258
P30 · FY2004 · CA
Cancer Genetics Program$19,898
P30 · FY2004 · CA
DEFECTIVE DNA MISMATCH REPAIR IN ENDOMETRIAL CANCERS$308,000
R01 · FY2003 · CA
rDNA Methylation and prognosis in Endometrial Cancers$153,000
R21 · FY2003 · CA
DEFECTIVE DNA MISMATCH REPAIR IN ENDOMETRIAL CANCERS$308,000
R01 · FY2002 · CA
CANCER GENETICS$0
P30 · FY2002 · CA
DEFECTIVE DNA MISMATCH REPAIR IN ENDOMETRIAL CANCERS$304,511
R01 · FY2001 · CA
CANCER GENETICS$0
P30 · FY2001 · CA
CLONING A UTERINE SEROUS CARCINOMA TUMOR SUPPRESSOR GENE$171,212
R01 · FY2000 · CA